2012
DOI: 10.1016/j.ejso.2012.02.178
|View full text |Cite
|
Sign up to set email alerts
|

Prospective trial of Adipose-Derived Regenerative Cell (ADRC)-enriched fat grafting for partial mastectomy defects: The RESTORE-2 trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
147
0
7

Year Published

2012
2012
2017
2017

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 178 publications
(155 citation statements)
references
References 19 publications
1
147
0
7
Order By: Relevance
“…A fat graft specimen contains mature adipocytes and preadipocytes, also known as adipose derived stem cells (ASC) 56,58,59 . ASCs have considerable angiogenic and antiapoptotic features and constitute 10% of the cell population, however graft survival is largely dependent on them given their huge proliferative contribution 14,40,[57][58][59] .…”
Section: Commented [Re8]: Are These Figure Pooled Results Frommentioning
confidence: 99%
“…A fat graft specimen contains mature adipocytes and preadipocytes, also known as adipose derived stem cells (ASC) 56,58,59 . ASCs have considerable angiogenic and antiapoptotic features and constitute 10% of the cell population, however graft survival is largely dependent on them given their huge proliferative contribution 14,40,[57][58][59] .…”
Section: Commented [Re8]: Are These Figure Pooled Results Frommentioning
confidence: 99%
“…29 cases resulted in improved and 35 cases sustained unchanged by LENT-SOMA scale for breast radiotherapy morphology. 50 out of 67 reported satisfactory in quality of life scale by SF-36v2 and there was an improvement in blinded MRI assessment in 54 out of 65 cases (18). ADRCs mixed with fat tissue have potential in cell therapy for radiation injury due to increasing neovascularization and retention of the fat property.…”
Section: Discussionmentioning
confidence: 99%
“…There are only limited data regarding the long-term oncological safety of lipofilling; however, one retrospective review did show that after a mean follow-up period of >40 months, fat grafting did not affect local tumour recurrence or survival (125). The most common complications with autologous fat grafting include fat necrosis (3.6%), oil cysts (1.8%) and infection (0.9%) (126)(127)(128). Complications appear to be higher with implant-based reconstructions compared with autologous flap reconstructions (129).…”
Section: What Is the Role Of Autologous Fat Grafting As An Adjuncmentioning
confidence: 99%